Targeted News Service

Goodwin Advises Envisagenics on Collaboration and License Agreement for Up To $1 Billion With Boehringer Ingelheim International GmbH
September 23, 2026

BOSTON, Massachusetts, Sept. 23 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Advises Envisagenics on Collaboration and License Agreement for Up To $1 Billion With Boehringer Ingelheim International GmbH

*

The Life Sciences team advised Envisagenics on a multi-year research collaboration and option agreement with Boehringer Ingelheim to validate selected tumor-specific targets for the developm . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form